The Science & Technology Corporation @UNM has licensed “Electron Paramagnetic Resonance Technology (EPR) for Melanoma Detection” to TenthGate Incorporated. The melanoscan is a molecular-based detection and imaging of melanoma technology based on the intrinsic and specific magnetic resonance properties of melanin.
The technology uses Electron Paramagnetic Resonance (EPR) to image primary melanomas, to detect metastasis and to measure melanoma prevention strategies. The unique EPR signature of melanin allows high selectivity.
STC President and CEO Lisa Kuuttila says, “We are pleased to sign this licensing agreement with TenthGate. We hope this will be the beginning of a fruitful relationship.”
About TenthGate
TenthGate Incorporated is a medical holding company strategically positioned to acquire, develop and commercialize “life-changing” healthcare and wellness technologies designed to enhance the effectiveness of medical diagnostics and treatment options. For more on TenthGate visit: TenthGate.
About STC
Science and Technology Corporation @ UNM is a nonprofit corporation formed by and owned entirely by the University of New Mexico to protect and transfer its faculty inventions into the commercial marketplace. STC licenses innovative technology developed at UNM, including optics, microfluidics, and high performance materials as well as therapeutics, diagnostics, medical devices and drug discovery tools.
Media Contact: Karen Wentworth, (505) 277-5627; e-mail: kwent2@unm.edu